196 related articles for article (PubMed ID: 10837969)
1. Dosimetric and volumetric criteria for selecting a source activity and a source type ((125)I or (103)Pd) in the presence of irregular seed placement in permanent prostate implants.
Wuu CS; Ennis RD; Schiff PB; Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):815-20. PubMed ID: 10837969
[TBL] [Abstract][Full Text] [Related]
2. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
[TBL] [Abstract][Full Text] [Related]
3. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
5. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
6. Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans.
D'Souza WD; Meyer RR
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1120-30. PubMed ID: 11704337
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
[TBL] [Abstract][Full Text] [Related]
8. Effect of random seed placement error in permanent transperineal prostate seed implant.
Bues M; Holupka EJ; Meskell P; Kaplan ID
Radiother Oncol; 2006 Apr; 79(1):70-4. PubMed ID: 16515813
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
10. Automated treatment planning engine for prostate seed implant brachytherapy.
Yu Y; Zhang JB; Brasacchio RA; Okunieff PG; Rubens DJ; Strang JG; Soni A; Messing EM
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):647-52. PubMed ID: 10078652
[TBL] [Abstract][Full Text] [Related]
11. On the determination of an effective planning volume for permanent prostate implants.
Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1197-206. PubMed ID: 11240263
[TBL] [Abstract][Full Text] [Related]
12. Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants.
Dawson JE; Wu T; Roy T; Gu JY; Kim H
Radiother Oncol; 1994 Sep; 32(3):268-70. PubMed ID: 7816946
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
Nath S; Chen Z; Yue N; Trumpore S; Peschel R
Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
[TBL] [Abstract][Full Text] [Related]
14. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative dynamic dose optimization in permanent prostate implants.
Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):854-61. PubMed ID: 12788195
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.
Chen Z; Yue N; Wang X; Roberts KB; Peschel R; Nath R
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1405-19. PubMed ID: 10889396
[TBL] [Abstract][Full Text] [Related]
17. Performance of a palladium-103 line source for prostate brachytherapy implants: A Phase I trial.
Stock R; Beyer D; Kaminetsky J; Ge W
Brachytherapy; 2017; 16(5):1007-1012. PubMed ID: 28757403
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
19. Effect of Foley catheters on seed positions and urethral dose in (125)I and (103)Pd prostate implants.
Brezovich IA; Pareek PN; Duan J; Fiveash J
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1461-8. PubMed ID: 11286854
[TBL] [Abstract][Full Text] [Related]
20. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
Todor DA; Barani IJ; Lin PS; Anscher MS
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):297-304. PubMed ID: 21536392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
